Henrietta Lacks' family sues Ultragenyx over use of immortal HeLa cell line, claiming unjust enrichment
2023-08-11
基因疗法专利侵权
The family of Henrietta Lacks has sued again over the use of her immortal cell line, this time going after Ultragenyx in Maryland District Court, alleging that its “competitive advantage” in gene therapy is the “theft” of Lacks’ cells.
The estate said in court documents filed Thursday that the company’s “ill-gotten gains” belong to the Lacks’ estate and that it wants the court to stop UltragenyxUltragenyx from using her cell line without the estate’s permission. Accusing Ultragenyx of unjust enrichment, the estate is also asking to be awarded the money the company has made from using the line.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。